Table of Contents

company-logo

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Artelo Biosciences Dividend Announcement

• Artelo Biosciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Artelo Biosciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Artelo Biosciences Dividend History

Artelo Biosciences Dividend Yield

Artelo Biosciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Artelo Biosciences stock? Use our calculator to estimate your expected dividend yield:

Artelo Biosciences Financial Ratios

P/E ratio-0.85
PEG ratio-0.04
P/B ratio0.23
ROE-26.25%
Payout ratio0.00%
Current ratio14.58
Quick ratio14.58
Cash Ratio2.87

Artelo Biosciences Dividend FAQ

Does Artelo Biosciences stock pay dividends?
Artelo Biosciences does not currently pay dividends to its shareholders.
Has Artelo Biosciences ever paid a dividend?
No, Artelo Biosciences has no a history of paying dividends to its shareholders. Artelo Biosciences is not known for its dividend payments.
Why doesn't Artelo Biosciences pay dividends?
There are several potential reasons why Artelo Biosciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Artelo Biosciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Artelo Biosciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Artelo Biosciences a dividend aristocrat?
Artelo Biosciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Artelo Biosciences a dividend king?
Artelo Biosciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Artelo Biosciences a dividend stock?
No, Artelo Biosciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Artelo Biosciences stocks?
To buy Artelo Biosciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Artelo Biosciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.